Clinical Study
Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
Table 1
Baseline characteristics of HCC patients with and without paraneoplastic syndromes (PNS).
| Variable | HCC patients with PNS () | HCC patients without PNS () | |
| Age | | | NS | Male sex | 110 (86.6%) | 280 (84.8%) | NS | Chinese race | 112 (88.2%) | 298 (90.3%) | NS | HBsAg positive | 82 (64.6%) | 197 (59.7%) | NS | Anti-HCV positive | 6 (4.7%) | 32 (9.7%) | NS | Significant alcohol intake | 38 (29.9%) | 97 (29.4%) | NS | Child-Pugh A/B/C | 57/53/17 (44.9%/41.7%/13.4%) | 146/135/49 (44.2%/40.9%/14.8%) | NS | Albumin, G/L | | | NS | Bilirubin, mol/L | | | NS | Prothrombin time, seconds | | | NS | Alanine transferase, U/L | | | NS | Aspartate transferase, U/L | | | NS |
|
|
Data presented as (%) or mean ± SD.
|